| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
elk-1, a Variant of Elk-1, Fails to Interact with the Serum Response Factor and Binds to DNA with Modulated SpecificityDepartment of Microbiology and Immunology, Jefferson Cancer Institute, Philadelphia, Pennsylvania 19107-5541
1 To whom requests for reprints should be addressed.
The ets oncogene superfamily codes for a family of transcriptional factors that are involved in gene regulation not only by autonomous DNA binding but also by indirect DNA binding through interaction with cellular factors. We have previously shown that a member of this superfamily, elk-1, is a sequence specific transcriptional activator, which forms a serum response factor (SRF) dependent ternary complex with serum response element (SRE) similar to p62TCF. We describe here an alternatively spliced variant of elk-1 named
elk-1, which has lost the SRF interaction domain, negative regulatory DNA binding domain, and part of the elk-1 DNA binding domain. This variant elk-1 protein has lost the capacity to form a SRF dependent ternary complex with SRE and to activate fos transcription. Since this splice variant lacks part of the ets DNA binding domain, it binds to DNA with a specificity that is different from that of the full length elk-1 protein. Therefore differential splicing within the DNA binding and protein-protein interaction domains of transcriptional factors can generate proteins with modulated DNA binding specificities and transcriptional regulation. Thus it is conceivable that variant elk-1 might function by competing for some of the elk-1 target sequences (like SRE) and thereby block the transcriptional activation of fos by SRF and elk-1. Alternately, variant elk-1 protein may be the repressor, recruited by the SRE bound SRF for c-fos repression, or it may have an altogether different function. Therefore, elk-1 appears to fall in the category of genes that encode activators and repressors through the mechanism of differential splicing.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 10/ 2/92. Accepted 11/25/92.
This article has been cited by other articles:
![]() |
A. Macdonald, K. Crowder, A. Street, C. McCormick, K. Saksela, and M. Harris The Hepatitis C Virus Non-structural NS5A Protein Inhibits Activating Protein-1 Function by Perturbing Ras-ERK Pathway Signaling J. Biol. Chem., May 9, 2003; 278(20): 17775 - 17784. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Jobling, Z. Fang, D. Koleski, and M. J. Tymms Expression of the ETS Transcription Factor ELF3 in the Retinal Pigment Epithelium Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3530 - 3537. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Giovane, A Pintzas, S M Maira, P Sobieszczuk, and B Wasylyk Net, a new ets transcription factor that is activated by Ras. Genes & Dev., July 1, 1994; 8(13): 1502 - 1513. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |